COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E5GO
|
|||
Drug Name |
PMID31955138-compound-16
|
|||
Synonyms |
PMID31955138-C-16
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Middle East Respiratory Syndrome (MERS) | Preclinical | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
Target | Top | |||
---|---|---|---|---|
Target(s) | MERS-CoV helicase (Hel) | Target Info | Inhibitor | [1] |
Halogenated triazole compound 16 performs to the active binding site of MERS-CoV helicase nsp13. |
References | Top | |||
---|---|---|---|---|
1 | Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors. Acta Pharm. 2020 Jun 1;70(2):145-159. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.